Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析

◆英語タイトル:Global Cardiovascular Innovation Center - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011687
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing advanced solutions for the diagnosis and treatment of cardiovascular disease. GCIC provides programs such as commercialization funding program, incubator program, and preclinical research and development facilities. The organization’s preclinical research and development facilities offers interventional and surgical resources to researchers, clinical investigators, interventionalists and surgeons for testing the next generation of devices and procedures, among others. GCIC is headquartered in Cleveland, Ohio, the US.

Global Cardiovascular Innovation Center – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Global Cardiovascular Innovation Center, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Global Cardiovascular Innovation Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Global Cardiovascular Innovation Center, Medical Equipment, Deal Details 10
Venture Financing 10
Securus Medical Raises USD10 Million in Series C Financing 10
Vectorious Medical Raises USD5 Million in Venture Financing 12
Juventas Therapeutics Raises US$22.2 Million In Series B Venture Financing Round 13
Global Cardiovascular Innovation Center – Key Competitors 15
Global Cardiovascular Innovation Center – Key Employees 16
Global Cardiovascular Innovation Center – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Global Cardiovascular Innovation Center, Medical Equipment, Key Facts 2
Global Cardiovascular Innovation Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Global Cardiovascular Innovation Center, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Global Cardiovascular Innovation Center, Deals By Market, 2011 to YTD 2017 8
Global Cardiovascular Innovation Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Securus Medical Raises USD10 Million in Series C Financing 10
Vectorious Medical Raises USD5 Million in Venture Financing 12
Juventas Therapeutics Raises US$22.2 Million In Series B Venture Financing Round 13
Global Cardiovascular Innovation Center, Key Competitors 15
Global Cardiovascular Innovation Center, Key Employees 16

★海外企業調査レポート[Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qatari German Medical Devices (QGMD):企業の財務及び戦略的SWOT分析
    Summary Qatari German Medical Devices (QG) is a medical device manufacturing company that manufactures and distributes disposable medical devices. The company’s products include Q Jectultra, Q Flow, Q Need, Q Ject, Q Safe, Breast Light and Sunmed. Its Q JectUltra is an insulin syringe serving as a t …
  • WesternZagros Resources Ltd. (WZR)(石油・ガス分野):企業M&A動向
    Summary WesternZagros Resources Ltd. (WesternZagros) is an oil and gas company. The company acquires, explores, develops and produces crude oil and natural gas. It holds two production sharing contracts with the Kurdistan Regional Government in the Kurdistan region of Iraq. It has drilled exploratio …
  • Plastopil Hazorea Company Ltd:企業概要・SWOT・財務分析
    Summary Canadean's "Plastopil Hazorea Company Ltd : Paper and Packaging - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busines …
  • H.I.G. Capital, LLC:企業概要及び戦略的SWOT分析
    H.I.G. Capital, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Louisiana-Pacific Corporation:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Louisiana-Pacific Corporation" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market …
  • Grant Thornton International Ltd.:企業の戦略・SWOT・財務分析
    SummaryGrant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • University of Illinois(製薬・医療分野):企業M&A動向
    Summary University of Illinois (UOL) is a public research university. The university offers undergraduate; graduate programs; and continuing and professional education. It also offers online and continuing education programs such as undergraduate and graduate online degrees. UOL offers research acti …
  • Black Hills Corporation:企業の戦略・SWOT・財務分析
    SummaryBlack Hills Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tennessee Valley Authority:企業のM&A・提携動向(発電分野)
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers, local power companies and distributors. The agency generates power using diverse sources of energy such as hydro, nuclear and other renewable based power plants. TVA provides flood control, n …
  • PT Dirgantara Indonesia:企業の戦略・SWOT・財務分析
    SummaryPT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Lifesensors, Inc.(製薬・医療分野):企業M&A動向
    Summary LifeSensors, Inc. (LifeSensors) is a biotechnology company. The company develops, manufactures and markets research tools for therapeutic, drug discovery, and research market. Its products include expression systems and ubiquitin research tools. The company provides services, such as custom …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Consol Glass (Pty) Limited:企業の戦略・SWOT・財務分析
    SummaryConsol Glass (Pty) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Central Reinsurance Corporation:企業の戦略・SWOT・財務分析
    SummaryCentral Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Novabase SGPS SA (NBA):企業財務及び戦略的SWOT分析
    Summary Novabase SGPS SA (Novabase) is an information technology solution provider that offers business solutions, and infrastructure and managed services. The company’s services include co-browse, IT contracting, risk, compliance and fraud management, customer insight, smartgrid, renewable solution …
  • Sygnis AG (LIO1)(製薬・医療分野):企業M&A動向
    Summary Sygnis AG (SYGNIS), formerly SYGNIS Pharma AG, is a biopharmaceutical company. It is focused on the development of novel products and tools in the fields of molecular biology for the fast-growing genomic and proteomic markets. The company undertakes the development and marketing of new molec …
  • RHB Capital Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RHB Capital Berhad Mergers and …
  • NanoBio Corporation(製薬・医療分野):企業M&A動向
    Summary NanoBio Corporation (NanoBio) is a biopharmaceutical company. The company develops and commercializes products for the prevention and treatment of infectious diseases. Its vaccines include anthrax, H5 influenza, HIV, HSV-2, pertussis, RSV, and seasonal influenza. NanoBio carries out research …
  • ASKA Pharmaceutical Co.Ltd.の企業概要及び財務/SWOT分析
    ASKA Pharmaceutical Co.Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and qua …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆